On 29 March 2022, leading business weekly magazine Usine Nouvelle published an interview with signatory of the Biotech Social Pact (BSP), Georges Rawadi, former CEO of Ysopia Biosciences and member of the board at Apmonia Therapeutics and Alia Therapeutics, and co-author of the BSP John Maraganore, former CEO and founder of Alnylam Pharmaceuticals. The interview has also been published in the monthly pharma magazine Industrie Pharma.
Georges Rawadi and John Maraganore call for more investments in the European biotech sector and a better reimbursement model. “The Social Contract for Biotechnology will be to create a platform bringing together the different actors to propose sustainable and alternative business models,” Rawadi said.
You can access the full interview on Usine Nouvelle.